(Q46547623)

English

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

1 reference

based on heuristic

inferred from title

electrophysiology

1 reference

based on heuristic

inferred from title

27

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

author name string

Ronan Depoortère

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Gihad Dargazanli

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Genevieve Estenne-Bouhtou

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Annick Coste

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Christophe Lanneau

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Christophe Desvignes

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Martine Poncelet

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Michel Heaulme

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Vincent Santucci

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Michel Decobert

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Annie Cudennec

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Carolle Voltz

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Denis Boulay

13

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Jean Paul Terranova

14

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Jeanne Stemmelin

15

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Pierre Roger

16

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Benoit Marabout

17

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Mireille Sevrin

18

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Xavier Vigé

19

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Bruno Biton

20

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Régis Steinberg

21

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Dominique Françon

22

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Richard Alonso

23

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Patrick Avenet

24

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Florence Oury-Donat

25

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Ghislaine Perrault

26

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Pascal George

28

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Philippe Soubrié

29

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Bernard Scatton

30

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

30

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

1963-1985

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300772

0 references

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Modulation of N-methyl-D-aspartate receptor function by glycine transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glutamate and anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Enhanced temporal resolution for the microdialysis monitoring of catecholamines and excitatory amino acids using capillary electrophoresis with laser-induced fluorescence detection. Analytical developments and in vitro validations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Memory and schizophrenia: differential link of processing speed and selective attention with two levels of encoding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Discovery and SAR of org 24598-a selective glycine uptake inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Negative symptoms in schizophrenia: neurobiological models and treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Acetylcholine modulation of neural systems involved in learning and memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Functional and anatomical aspects of prefrontal pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Free D-aspartate and D-serine in the mammalian brain and periphery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Hippocampal neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glutamate receptor function in learning and memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Episodic memory and learning in patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

D-serine added to antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glycine transport inhibitors as potential antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

21 January 2018

ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Distress vocalizations in maternally separated mouse pups: modulation via 5-HT 1A , 5-HT 1B and GABA A receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Distress vocalization in rat pups. A simple screening method for anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjunctive high-dose glycine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycine regulation of synaptic NMDA receptors in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300772

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300772

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15956994

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46547623&oldid=2183094748"